GO:0019682 glyceraldehyde-3-phosphate metabolic process: Glycolytic Intermediate Hub, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019682 describes the chemical reactions and pathways involving glyceraldehyde-3-phosphate (G3P), a central intermediate in glycolysis and a branch point for several metabolic routes.
• Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is the best-characterized enzyme acting on G3P, catalyzing its oxidative phosphorylation to 1,3-bisphosphoglycerate during glycolysis.
• Beyond glycolysis, G3P participates in the pentose phosphate pathway and non-enzymatic reactions, such as those with carnosine, linking it to redox and carbonyl metabolism.
• GAPDH, a key G3P-metabolizing enzyme, has non-glycolytic roles in DNA repair, apoptosis, and neurodegeneration, making G3P metabolism relevant to multiple diseases.
• GAPDH is a redox-sensitive protein; its inactivation by peroxynitrite and oxidation by ascorbate modulate G3P flux and cellular stress responses.
• Studying GO:0019682 requires integrating genetic models (knockout, point mutation, knock-in, overexpression) with metabolic, proteomic, and imaging methods to dissect pathway function and regulation.
Description
Glyceraldehyde-3-phosphate metabolic process (GO:0019682) encompasses the chemical reactions and pathways involving glyceraldehyde-3-phosphate (G3P), an important intermediate in glycolysis. G3P sits at a metabolic crossroads: it is produced by the cleavage of fructose-1,6-bisphosphate and consumed by glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to generate 1,3-bisphosphoglycerate, a substrate for ATP production. This process is not limited to energy metabolism; G3P also feeds into the pentose phosphate pathway and can undergo non-enzymatic modifications that affect cellular redox balance. Researchers study GO:0019682 because G3P metabolism is intimately linked to fundamental cellular processes, including glycolysis, gluconeogenesis, and the pentose phosphate pathway. The enzymes that act on G3P, particularly GAPDH, have been implicated in diverse pathologies such as Alzheimer's disease, where GAPDH dysfunction contributes to pathogenesis. Moreover, GAPDH is a target of oxidative modifications, including inactivation by peroxynitrite and ascorbate-induced oxidation, which can alter metabolic flux and cell survival. Understanding the regulation and broader roles of G3P metabolism is therefore critical for cancer biology, neurodegeneration, and metabolic disorders. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0019682, its key genes, disease connections, and experimental strategies for investigation.
glyceraldehyde-3-phosphate metabolic process At A Glance
| GO ID | GO:0019682 |
|---|---|
| GO term | glyceraldehyde-3-phosphate metabolic process |
| Ontology | biological_process |
| Synonym | glyceraldehyde 3-phosphate metabolic process; glyceraldehyde 3-phosphate metabolism; glyceraldehyde-3-phosphate metabolism |
| Definition | The chemical reactions and pathways involving glyceraldehyde-3-phosphate, an important intermediate in glycolysis. |
| Major function | Metabolism of glyceraldehyde-3-phosphate, a key intermediate in glycolysis and related pathways. |
| Key enzyme | Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) catalyzes the oxidative phosphorylation of G3P. |
| Related pathways | Glycolysis, pentose phosphate pathway, gluconeogenesis. |
| Disease relevance | Neurodegeneration, oxidative stress, cancer metabolism. |
What Is GO:0019682?
GO:0019682, glyceraldehyde-3-phosphate metabolic process, is defined by QuickGO as the chemical reactions and pathways involving glyceraldehyde-3-phosphate, an important intermediate in glycolysis. In other words, it covers all enzymatic and non-enzymatic transformations of G3P, including its oxidation, reduction, phosphorylation, and interconversion with other metabolites, as well as its role as a substrate in central carbon metabolism.
Why Is glyceraldehyde-3-phosphate metabolic process Important in Cell Biology?
Glyceraldehyde-3-phosphate metabolic process is fundamental to cellular energy production and biosynthetic pathways. As a central intermediate in glycolysis, G3P is rapidly converted by GAPDH to 1,3-bisphosphoglycerate, a step that generates NADH and subsequently ATP. This process also intersects with the pentose phosphate pathway, influencing NADPH production and nucleotide biosynthesis. Dysregulation of G3P metabolism has been linked to oxidative stress, where GAPDH inactivation by peroxynitrite or ascorbate can redirect metabolic flux and contribute to cell death. Furthermore, GAPDH, the primary enzyme in this process, has non-glycolytic functions in DNA repair and apoptosis, and its aggregation is associated with amyloid neurodegenerative diseases. Thus, understanding GO:0019682 is essential for deciphering metabolic reprogramming in cancer, neurodegeneration, and other human disorders.
• Central to glycolysis and ATP production, providing energy for cellular functions.
• Links glycolysis to the pentose phosphate pathway, affecting NADPH and nucleotide synthesis.
• GAPDH, the key enzyme, is a redox sensor; its oxidation by peroxynitrite or ascorbate modulates metabolic flux.
• GAPDH has non-glycolytic roles in DNA repair and apoptosis, expanding the impact of G3P metabolism.
• GAPDH aggregation is implicated in amyloid neurodegenerative diseases such as Alzheimer's.
• Non-enzymatic reactions of G3P with carnosine affect carbonyl stress and metabolic changes.
• G3P metabolism is a target for understanding cancer metabolic reprogramming (Warburg effect).
• Enzymes of G3P metabolism are potential therapeutic targets in oxidative stress-related disorders.
• Research tools for GO:0019682 include genetic models and metabolic profiling.
• Studying G3P metabolism helps elucidate evolutionary adaptations, such as non-phosphorylating GAPDH.
What Happens During glyceraldehyde-3-phosphate metabolic process?
Glycolytic Oxidation of G3P by GAPDH
In simple terms: G3P is converted into a high-energy molecule that helps make ATP.
The central reaction of GO:0019682 is the oxidative phosphorylation of glyceraldehyde-3-phosphate (G3P) to 1,3-bisphosphoglycerate, catalyzed by glyceraldehyde-3-phosphate dehydrogenase (GAPDH). This NAD+-dependent reaction generates NADH and a high-energy acyl phosphate intermediate, which subsequently drives ATP synthesis. GAPDH is a tetrameric enzyme highly conserved across species, and its catalytic mechanism involves a cysteine residue that forms a thioester intermediate.
Non-phosphorylating G3P Oxidation
In simple terms: Some organisms use a different enzyme to convert G3P without making ATP.
In certain bacteria and archaea, a non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase (GAPN) directly oxidizes G3P to 3-phosphoglycerate, producing NADPH instead of NADH. This alternative route bypasses the ATP-generating step and is important for maintaining redox balance and providing reducing power for biosynthesis.
Non-enzymatic Reactions of G3P
In simple terms: G3P can react with other molecules without enzymes, affecting metabolism.
G3P can undergo non-enzymatic reactions, such as with carnosine, leading to metabolic changes in the pentose phosphate pathway. These reactions can modulate carbonyl stress and influence cellular redox status, highlighting that GO:0019682 includes spontaneous chemical processes beyond enzyme-catalyzed steps.
Redox Regulation of G3P Metabolism
In simple terms: Oxidative stress can damage the enzyme that processes G3P, slowing the pathway.
GAPDH is sensitive to oxidative modifications. Peroxynitrite inactivates GAPDH by modifying its active-site cysteine, leading to decreased G3P oxidation and potential metabolic rerouting. Similarly, ascorbate-induced oxidation of GAPDH can inhibit its activity. These modifications link G3P metabolism to cellular redox signaling and stress responses.
Key Genes Involved in GO:0019682 glyceraldehyde-3-phosphate metabolic process
The following genes and proteins are directly involved in glyceraldehyde-3-phosphate metabolic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GAPDH | Catalyzes oxidative phosphorylation of G3P to 1,3-bisphosphoglycerate in glycolysis | Central enzyme; target for oxidative stress, neurodegeneration, and cancer studies |
| GAPN (non-phosphorylating GAPDH) | Directly oxidizes G3P to 3-phosphoglycerate, producing NADPH | Studied in bacteria and archaea for redox balance and evolution |
| ALDH (aldehyde dehydrogenase) | May act on G3P or its derivatives in non-enzymatic reactions | Relevant to carbonyl metabolism and pentose phosphate pathway crosstalk |
| TPI (triosephosphate isomerase) | Interconverts dihydroxyacetone phosphate and G3P | Upstream of G3P in glycolysis; affects G3P supply |
| PGK (phosphoglycerate kinase) | Converts 1,3-bisphosphoglycerate to 3-phosphoglycerate, generating ATP | Downstream of GAPDH; links G3P metabolism to ATP production |
| PKM (pyruvate kinase) | Catalyzes final step of glycolysis, downstream of G3P | Affects glycolytic flux and G3P consumption |
| LDHA | Converts pyruvate to lactate, regenerating NAD+ for GAPDH | Supports high glycolytic flux in cancer |
| G6PD | Pentose phosphate pathway enzyme, competes for G3P precursors | Links G3P metabolism to NADPH production |
| TALDO1 | Transaldolase in pentose phosphate pathway | Interacts with G3P metabolism via non-enzymatic reactions |
| PRPS1 | Phosphoribosyl pyrophosphate synthetase, uses ribose-5-phosphate from PPP | Connects G3P metabolism to nucleotide synthesis |
| SOD1 | Superoxide dismutase, protects GAPDH from oxidative inactivation | Modulates redox state affecting GAPDH activity |
| NOS2 | Inducible nitric oxide synthase, produces NO leading to peroxynitrite | Can inactivate GAPDH via peroxynitrite |
| CASP3 | Caspase-3, cleaves GAPDH during apoptosis | Links G3P metabolism to cell death |
| HSPA1A | Heat shock protein 70, interacts with GAPDH | Chaperone for GAPDH folding and aggregation |
| APP | Amyloid precursor protein, interacts with GAPDH in Alzheimer's | GAPDH aggregation in neurodegeneration |
| TXN | Thioredoxin, reduces oxidized GAPDH | Regulates GAPDH redox state |
| GLO1 | Glyoxalase 1, detoxifies methylglyoxal from G3P | Links G3P metabolism to carbonyl stress |
How Is glyceraldehyde-3-phosphate metabolic process Regulated?
Glyceraldehyde-3-phosphate metabolic process is regulated at multiple levels. The activity of GAPDH, the key enzyme, is modulated by redox modifications: peroxynitrite inactivates GAPDH, while ascorbate-induced oxidation also inhibits its activity. Conversely, reducing agents such as thioredoxin can restore activity. Additionally, GAPDH expression is regulated transcriptionally and post-translationally, including by S-nitrosylation and phosphorylation. The non-phosphorylating GAPN provides an alternative route in some organisms, regulated by NADP+/NADPH ratios. Non-enzymatic reactions with carnosine can also influence G3P availability and pathway flux. Overall, regulation ensures metabolic flexibility in response to cellular energy status and oxidative stress.
glyceraldehyde-3-phosphate metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GAPDH | Alzheimer's disease, neurodegeneration | Knockout or point-mutation in neuronal cell lines; aggregation assays |
| GAPDH | Cancer metabolism (Warburg effect) | Overexpression in cancer cell lines; xenograft models |
| GAPDH | Oxidative stress response | Point mutation of active-site cysteine; treatment with peroxynitrite |
| GAPN | Bacterial redox balance | Knockout in bacterial strains; NADPH measurement |
| GLO1 | Carbonyl stress, diabetes complications | Overexpression or knockout in cell models; methylglyoxal treatment |
G3P Metabolism in Neurodegenerative Diseases
GAPDH, the central enzyme in G3P metabolism, is implicated in Alzheimer's disease pathogenesis. Oxidative stress can cause GAPDH aggregation, which is associated with amyloid neurodegenerative diseases. GAPDH inactivation by peroxynitrite may contribute to neuronal dysfunction by impairing glycolysis and energy production. These findings link GO:0019682 to neurodegeneration and highlight GAPDH as a potential therapeutic target.
G3P Metabolism and Cancer
Cancer cells often exhibit increased glycolysis (Warburg effect), relying on GAPDH for rapid ATP production and biosynthetic intermediates. GAPDH overexpression is observed in many cancers, and its inhibition can reduce tumor growth. Additionally, GAPDH has non-glycolytic roles in DNA repair that may support cancer cell survival. Thus, G3P metabolism is a key metabolic node in cancer biology.
Oxidative Stress and G3P Metabolism
GAPDH is a redox-sensitive enzyme; its inactivation by peroxynitrite and ascorbate-induced oxidation can redirect G3P flux and affect cellular redox balance. This has implications for diseases characterized by oxidative stress, such as inflammation and ischemia-reperfusion injury. Non-enzymatic reactions of G3P with carnosine also modulate carbonyl stress, linking G3P metabolism to detoxification pathways.
From glyceraldehyde-3-phosphate metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GAPDH loss affect glycolysis and cell viability? | GAPDH knockout cell lines (e.g., HeLa, HEK293) |
| How does oxidative modification of GAPDH alter G3P flux? | Point mutation of active-site cysteine (C152S) knock-in |
| Can GAPDH aggregation be monitored in live cells? | Tagged knock-in of GAPDH with fluorescent protein |
| Does GAPDH overexpression promote cancer growth? | Overexpression in cancer cell lines and mouse xenografts |
| What is the role of non-phosphorylating GAPN in bacteria? | Knockout of gapN in bacterial strains |
| How does carnosine affect G3P metabolism? | Overexpression of carnosine synthase in cell models |
How to Study the glyceraldehyde-3-phosphate metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Levels of G3P and glycolytic intermediates | Quantifying pathway flux in cells |
| GAPDH activity assay | NADH production from G3P oxidation | Assessing enzyme kinetics and inhibition |
| Redox proteomics | Oxidative modifications on GAPDH | Identifying cysteine oxidation in disease models |
| Western blot | GAPDH protein levels and aggregation | Detecting aggregation in neurodegeneration |
| Immunofluorescence | Subcellular localization of GAPDH | Studying translocation in apoptosis |
| CRISPR screening | Genes affecting G3P metabolism | Identifying synthetic lethal interactions |
| RNA-seq | Transcriptional changes in glycolytic genes | Evaluating pathway regulation |
| Seahorse assay | Extracellular acidification and oxygen consumption | Measuring glycolytic flux |
Metabolic Profiling
Metabolic profiling using mass spectrometry or NMR can quantify G3P and related metabolites in cell extracts. This allows researchers to assess flux through GO:0019682 under different conditions, such as oxidative stress or genetic perturbations.
Enzyme Activity Assays
GAPDH activity can be measured spectrophotometrically by monitoring NADH production at 340 nm. This method is used to assess the impact of mutations or oxidative modifications on G3P metabolism.
Proteomic and Redox Analysis
Proteomic approaches, including redox proteomics, can identify oxidative modifications on GAPDH and other enzymes of G3P metabolism. These techniques help elucidate regulatory mechanisms and disease-associated changes.
Imaging and Localization
Fluorescence microscopy with tagged GAPDH or G3P sensors can reveal subcellular localization and dynamics of G3P metabolism. This is particularly useful for studying GAPDH aggregation in neurodegeneration.
How CRISPR Can Be Used to Study GO:0019682 glyceraldehyde-3-phosphate metabolic process
Knockout
CRISPR knockout of GAPDH or other genes in GO:0019682 can reveal their essentiality. However, complete GAPDH knockout may be lethal in many cell types, so conditional or inducible systems are recommended. Knockout of non-essential genes like GAPN in bacteria can be used to study alternative G3P oxidation.
Point Mutation
Point mutations in the active site of GAPDH (e.g., C152S) can abolish catalytic activity while preserving protein structure, allowing dissection of enzymatic versus non-glycolytic functions. Such models are valuable for studying oxidative inactivation.
Knock-in
Knock-in of tagged GAPDH (e.g., GFP or HA) enables live-cell imaging and proteomic analysis of G3P metabolism. Knock-in of disease-associated mutations can model neurodegeneration.
Overexpression
Overexpression of GAPDH or GAPN can increase flux through G3P metabolism, useful for studying cancer metabolism or redox balance. Overexpression of carnosine synthase can modulate non-enzymatic G3P reactions.
How EDITGENE Supports glyceraldehyde-3-phosphate metabolic process Research
Researchers studying glyceraldehyde-3-phosphate metabolic process-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, disease pathogenesis, or therapeutic response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes in GO:0019682.
Contact EDITGENE today to design your custom CRISPR model for glyceraldehyde-3-phosphate metabolic process research.
Frequently Asked Questions About glyceraldehyde-3-phosphate metabolic process
What is glyceraldehyde-3-phosphate metabolic process?
It is the set of chemical reactions and pathways involving glyceraldehyde-3-phosphate (G3P), a key intermediate in glycolysis, as defined by GO:0019682.
What genes are involved in glyceraldehyde-3-phosphate metabolic process?
Key genes include GAPDH, which encodes the enzyme that oxidizes G3P, and GAPN, a non-phosphorylating alternative in some organisms.
What is the role of GAPDH in G3P metabolism?
GAPDH catalyzes the NAD+-dependent oxidative phosphorylation of G3P to 1,3-bisphosphoglycerate, a crucial step in glycolysis.
How is glyceraldehyde-3-phosphate metabolic process regulated?
It is regulated by redox modifications of GAPDH, such as inactivation by peroxynitrite or ascorbate, and by expression levels.
What diseases are associated with G3P metabolism?
Alzheimer's disease and other neurodegenerative disorders have been linked to GAPDH dysfunction and aggregation.
Can CRISPR be used to study G3P metabolism?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes like GAPDH to study their functions.
What methods are used to study glyceraldehyde-3-phosphate metabolic process?
Common methods include metabolic profiling, enzyme activity assays, redox proteomics, and imaging of tagged proteins.
Why is GAPDH considered a moonlighting protein?
Beyond glycolysis, GAPDH participates in DNA repair, apoptosis, and other processes, expanding its roles beyond G3P metabolism.
How does oxidative stress affect G3P metabolism?
Oxidative stress can inactivate GAPDH through modifications like peroxynitrite, reducing G3P oxidation and altering metabolic flux.
What is the non-phosphorylating GAPDH?
It is an enzyme (GAPN) that directly oxidizes G3P to 3-phosphoglycerate, producing NADPH, found in some bacteria and archaea.
Conclusion
Glyceraldehyde-3-phosphate metabolic process (GO:0019682) is a fundamental biological process centered on the metabolism of G3P, a key glycolytic intermediate. The enzyme GAPDH plays a pivotal role, and its dysfunction is linked to neurodegeneration, oxidative stress, and cancer. Understanding the regulation and broader implications of this pathway requires integrated approaches, including CRISPR-based genetic models and metabolic profiling. EDITGENE provides tailored services to support such research, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. White MR et al.. 2017. D-Glyceraldehyde-3-Phosphate Dehydrogenase Structure and Function.. Subcell Biochem 83:413-453 PMID: 28271485
- 2. Schmalhausen EV et al.. 2024. Glyceraldehyde-3-phosphate dehydrogenase is involved in the pathogenesis of Alzheimer's disease.. Arch Biochem Biophys 758:110065 PMID: 38906311
- 3. Souza JM et al.. 1998. Glyceraldehyde-3-phosphate dehydrogenase inactivation by peroxynitrite.. Arch Biochem Biophys 360(2):187-94 PMID: 9851830
- 4. Kosova AA et al.. 2017. Role of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) in DNA Repair.. Biochemistry (Mosc) 82(6):643-654 PMID: 28601074
- 5. Oppermann H et al.. 2020. Non-enzymatic reaction of carnosine and glyceraldehyde-3-phosphate accompanies metabolic changes of the pentose phosphate pathway.. Cell Prolif 53(2):e12702 PMID: 31628715
- 6. Muronetz VI et al.. 2017. Glyceraldehyde-3-phosphate dehydrogenase: Aggregation mechanisms and impact on amyloid neurodegenerative diseases.. Int J Biol Macromol 100:55-66 PMID: 27215901
- 7. Habenicht A. 1997. The non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase: biochemistry, structure, occurrence and evolution.. Biol Chem 378(12):1413-9 PMID: 9461340
- 8. Schmalhausen EV et al.. 2003. Ascorbate-induced oxidation of glyceraldehyde-3-phosphate dehydrogenase.. Biochem Biophys Res Commun 308(3):492-6 PMID: 12914777
